HomeCompareASXC vs CL

ASXC vs CL: Dividend Comparison 2026

ASXC yields 574.88% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASXC wins by $183655.94M in total portfolio value
10 years
ASXC
ASXC
● Live price
574.88%
Share price
$0.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$183655.98M
Annual income
$136,833,479,194.82
Full ASXC calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — ASXC vs CL

📍 ASXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASXCCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASXC + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASXC pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASXC
Annual income on $10K today (after 15% tax)
$48,864.62/yr
After 10yr DRIP, annual income (after tax)
$116,308,457,315.60/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, ASXC beats the other by $116,308,452,723.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASXC + CL for your $10,000?

ASXC: 50%CL: 50%
100% CL50/50100% ASXC
Portfolio after 10yr
$91828.01M
Annual income
$68,416,742,298.39/yr
Blended yield
74.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

ASXC
Analyst Ratings
2
Hold
Consensus: Hold
Price Target
$1.50
+331.2% upside vs current
Range: $1.50 — $1.50
Altman Z
-41.9
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASXC buys
0
CL buys
0
No recent congressional trades found for ASXC or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASXCCL
Forward yield574.88%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$183655.98M$40.8K
Annual income after 10y$136,833,479,194.82$5,401.96
Total dividends collected$179712.33M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold
Analyst price target$1.50$92.45

Year-by-year: ASXC vs CL ($10,000, DRIP)

YearASXC PortfolioASXC Income/yrCL PortfolioCL Income/yrGap
1← crossover$68,188$57,487.78$11,012$312.01+$57.2KASXC
2$439,313$366,351.83$12,196$412.95+$427.1KASXC
3$2,675,944$2,205,879.72$13,599$549.66+$2.66MASXC
4$15,420,706$12,557,445.87$15,288$736.64+$15.41MASXC
5$84,130,987$67,630,830.90$17,353$995.28+$84.11MASXC
6$434,856,205$344,836,049.27$19,926$1,357.80+$434.84MASXC
7$2,131,079,702$1,665,783,562.49$23,194$1,873.82+$2131.06MASXC
8$9,909,627,711$7,629,372,430.43$27,439$2,621.52+$9909.60MASXC
9$43,759,343,910$33,156,042,258.68$33,088$3,727.38+$43759.31MASXC
10$183,655,977,178$136,833,479,194.82$40,806$5,401.96+$183655.94MASXC

ASXC vs CL: Complete Analysis 2026

ASXCStock

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Full ASXC Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this ASXC vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASXC vs SCHDASXC vs JEPIASXC vs OASXC vs KOASXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.